Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02100007 |
Title | ME-344 Given in Combination With Hycamtin in Patients With Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | MEI Pharma, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Pinnacle Oncology Hematology | Scottsdale | Arizona | 85258 | United States | Details | |
University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
Oncology Hematology Care | Cincinnati | Ohio | 45242 | United States | Details | |
University of Oklahoma | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Medical University of South Carolina | Charleston | South Carolina | 29425 | United States | Details | |
Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | United States | Details | |
University of WA Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
The Bays St Mary's Hospital | London | England | W2 1NY | United Kingdom | Details | |
Sarah Cannon Research Instititute UK | London | England | WIG 6AD | United Kingdom | Details |